BUILDERS FIRSTSOURCE INC (BLDR) Stock Fundamental Analysis
USA - NYSE:BLDR - US12008R1077 - Common Stock
139.96 USD
-2.77 (-1.94%)
Overall BLDR gets a fundamental rating of 4 out of 10. We evaluated BLDR against 41 industry peers in the Building Products industry. BLDR has a medium profitability rating, but doesn't score so well on its financial health evaluation. BLDR has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year BLDR was profitable.
In the past year BLDR had a positive cash flow from operations.
BLDR had positive earnings in each of the past 5 years.
BLDR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 6.60%, BLDR is in line with its industry, outperforming 53.66% of the companies in the same industry.
The Return On Equity of BLDR (18.10%) is better than 68.29% of its industry peers.
BLDR has a Return On Invested Capital of 9.90%. This is comparable to the rest of the industry: BLDR outperforms 56.10% of its industry peers.
BLDR had an Average Return On Invested Capital over the past 3 years of 22.36%. This is significantly above the industry average of 12.76%.
The 3 year average ROIC (22.36%) for BLDR is well above the current ROIC(9.90%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.6% | ||
| ROE | 18.1% | ||
| ROIC | 9.9% |
ROA(3y)16.93%
ROA(5y)14.89%
ROE(3y)37.68%
ROE(5y)35.24%
ROIC(3y)22.36%
ROIC(5y)20.5%
1.3 Margins
With a Profit Margin value of 4.74%, BLDR is not doing good in the industry: 63.41% of the companies in the same industry are doing better.
BLDR's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 7.70%, BLDR is doing worse than 65.85% of the companies in the same industry.
In the last couple of years the Operating Margin of BLDR has grown nicely.
The Gross Margin of BLDR (31.58%) is comparable to the rest of the industry.
BLDR's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.7% | ||
| PM (TTM) | 4.74% | ||
| GM | 31.58% |
OM growth 3Y-6.99%
OM growth 5Y12.55%
PM growth 3Y-8.82%
PM growth 5Y16.6%
GM growth 3Y3.73%
GM growth 5Y3.86%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), BLDR is creating value.
BLDR has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, BLDR has less shares outstanding
The debt/assets ratio for BLDR is higher compared to a year ago.
2.2 Solvency
BLDR has a debt to FCF ratio of 3.93. This is a good value and a sign of high solvency as BLDR would need 3.93 years to pay back of all of its debts.
BLDR has a Debt to FCF ratio of 3.93. This is comparable to the rest of the industry: BLDR outperforms 51.22% of its industry peers.
A Debt/Equity ratio of 1.12 is on the high side and indicates that BLDR has dependencies on debt financing.
BLDR has a worse Debt to Equity ratio (1.12) than 82.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.12 | ||
| Debt/FCF | 3.93 | ||
| Altman-Z | N/A |
ROIC/WACC0.98
WACC10.1%
2.3 Liquidity
A Current Ratio of 1.79 indicates that BLDR should not have too much problems paying its short term obligations.
BLDR has a Current ratio (1.79) which is in line with its industry peers.
BLDR has a Quick Ratio of 1.08. This is a normal value and indicates that BLDR is financially healthy and should not expect problems in meeting its short term obligations.
BLDR has a Quick ratio of 1.08. This is in the lower half of the industry: BLDR underperforms 63.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.08 |
3. Growth
3.1 Past
BLDR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33.50%.
BLDR shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 40.71% yearly.
Looking at the last year, BLDR shows a decrease in Revenue. The Revenue has decreased by -6.39% in the last year.
The Revenue has been growing by 17.64% on average over the past years. This is quite good.
EPS 1Y (TTM)-33.5%
EPS 3Y4.76%
EPS 5Y40.71%
EPS Q2Q%-32%
Revenue 1Y (TTM)-6.39%
Revenue growth 3Y-6.23%
Revenue growth 5Y17.64%
Sales Q2Q%-4.99%
3.2 Future
Based on estimates for the next years, BLDR will show a decrease in Earnings Per Share. The EPS will decrease by -7.26% on average per year.
Based on estimates for the next years, BLDR will show a small growth in Revenue. The Revenue will grow by 0.03% on average per year.
EPS Next Y-38.95%
EPS Next 2Y-20%
EPS Next 3Y-7.26%
EPS Next 5YN/A
Revenue Next Year-7%
Revenue Next 2Y-2.59%
Revenue Next 3Y0.03%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 15.10, which indicates a correct valuation of BLDR.
Based on the Price/Earnings ratio, BLDR is valued cheaper than 80.49% of the companies in the same industry.
BLDR's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.30.
BLDR is valuated rather expensively with a Price/Forward Earnings ratio of 18.97.
BLDR's Price/Forward Earnings ratio is in line with the industry average.
BLDR's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.73.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.1 | ||
| Fwd PE | 18.97 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BLDR is valued a bit cheaper than the industry average as 73.17% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, BLDR is valued cheaply inside the industry as 90.24% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.02 | ||
| EV/EBITDA | 11.32 |
4.3 Compensation for Growth
BLDR has a very decent profitability rating, which may justify a higher PE ratio.
BLDR's earnings are expected to decrease with -7.26% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.37
EPS Next 2Y-20%
EPS Next 3Y-7.26%
5. Dividend
5.1 Amount
BLDR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:BLDR (9/15/2025, 3:01:09 PM)
139.96
-2.77 (-1.94%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)
Earnings (Next)
Inst Owners99.83%
Inst Owner Change-1.46%
Ins Owners2.49%
Ins Owner Change4.68%
Market Cap15.47B
Analysts77.04
Price Target142.66 (1.93%)
Short Float %6.04%
Short Ratio2.81
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.42%
Min EPS beat(2)2.38%
Max EPS beat(2)12.47%
EPS beat(4)4
Avg EPS beat(4)6.07%
Min EPS beat(4)1.07%
Max EPS beat(4)12.47%
EPS beat(8)8
Avg EPS beat(8)12.44%
EPS beat(12)12
Avg EPS beat(12)27.52%
EPS beat(16)16
Avg EPS beat(16)42.11%
Revenue beat(2)0
Avg Revenue beat(2)-2.44%
Min Revenue beat(2)-2.96%
Max Revenue beat(2)-1.92%
Revenue beat(4)0
Avg Revenue beat(4)-7.3%
Min Revenue beat(4)-17.56%
Max Revenue beat(4)-1.92%
Revenue beat(8)1
Avg Revenue beat(8)-4.98%
Revenue beat(12)5
Avg Revenue beat(12)-1.63%
Revenue beat(16)9
Avg Revenue beat(16)2.64%
PT rev (1m)1.29%
PT rev (3m)-1.53%
EPS NQ rev (1m)-5.67%
EPS NQ rev (3m)-31.44%
EPS NY rev (1m)-14.61%
EPS NY rev (3m)-16.01%
Revenue NQ rev (1m)-1.13%
Revenue NQ rev (3m)-11.97%
Revenue NY rev (1m)-5.64%
Revenue NY rev (3m)-6.35%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.1 | ||
| Fwd PE | 18.97 | ||
| P/S | 0.97 | ||
| P/FCF | 13.02 | ||
| P/OCF | 9.81 | ||
| P/B | 3.7 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.32 |
EPS(TTM)9.27
EY6.62%
EPS(NY)7.38
Fwd EY5.27%
FCF(TTM)10.75
FCFY7.68%
OCF(TTM)14.26
OCFY10.19%
SpS144.23
BVpS37.79
TBVpS-9.71
PEG (NY)N/A
PEG (5Y)0.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.6% | ||
| ROE | 18.1% | ||
| ROCE | 12.75% | ||
| ROIC | 9.9% | ||
| ROICexc | 9.99% | ||
| ROICexgc | 22.22% | ||
| OM | 7.7% | ||
| PM (TTM) | 4.74% | ||
| GM | 31.58% | ||
| FCFM | 7.46% |
ROA(3y)16.93%
ROA(5y)14.89%
ROE(3y)37.68%
ROE(5y)35.24%
ROIC(3y)22.36%
ROIC(5y)20.5%
ROICexc(3y)22.6%
ROICexc(5y)21.09%
ROICexgc(3y)52.47%
ROICexgc(5y)46.44%
ROCE(3y)28.8%
ROCE(5y)26.39%
ROICexcg growth 3Y-14.33%
ROICexcg growth 5Y9.79%
ROICexc growth 3Y-13.16%
ROICexc growth 5Y2.57%
OM growth 3Y-6.99%
OM growth 5Y12.55%
PM growth 3Y-8.82%
PM growth 5Y16.6%
GM growth 3Y3.73%
GM growth 5Y3.86%
F-Score4
Asset Turnover1.39
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.12 | ||
| Debt/FCF | 3.93 | ||
| Debt/EBITDA | 2.6 | ||
| Cap/Depr | 67.97% | ||
| Cap/Sales | 2.43% | ||
| Interest Coverage | 5.27 | ||
| Cash Conversion | 87.67% | ||
| Profit Quality | 157.18% | ||
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.08 | ||
| Altman-Z | N/A |
F-Score4
WACC10.1%
ROIC/WACC0.98
Cap/Depr(3y)73.83%
Cap/Depr(5y)71.85%
Cap/Sales(3y)2.2%
Cap/Sales(5y)1.81%
Profit Quality(3y)125.27%
Profit Quality(5y)102.16%
High Growth Momentum
Growth
EPS 1Y (TTM)-33.5%
EPS 3Y4.76%
EPS 5Y40.71%
EPS Q2Q%-32%
EPS Next Y-38.95%
EPS Next 2Y-20%
EPS Next 3Y-7.26%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.39%
Revenue growth 3Y-6.23%
Revenue growth 5Y17.64%
Sales Q2Q%-4.99%
Revenue Next Year-7%
Revenue Next 2Y-2.59%
Revenue Next 3Y0.03%
Revenue Next 5YN/A
EBIT growth 1Y-38.45%
EBIT growth 3Y-12.79%
EBIT growth 5Y32.41%
EBIT Next Year1.15%
EBIT Next 3Y6.94%
EBIT Next 5YN/A
FCF growth 1Y-61.23%
FCF growth 3Y-0.52%
FCF growth 5Y30.71%
OCF growth 1Y-55.18%
OCF growth 3Y2.41%
OCF growth 5Y30.02%